MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-06-2026
Canopy Growth Corporation DPO Ratio 2011-2026 | CGC
Annual DPO Ratio Canopy Growth Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.8 | 51.1 | 44.2 | 36.2 | 72.5 | 105 | 0.417 | 375 | - | - | - | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 375 | 0.417 | 92.1 |
Quarterly DPO Ratio Canopy Growth Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 56.5 | 19.1 | 23.2 | - | 59.7 | 60.8 | 88.9 | 54.2 | - | - | 119 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in CAD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 119 | 19.1 | 60.2 |
DPO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
38 | - | 7.5 % | $ 6.35 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
345 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
116 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
352 | - | 10.11 % | $ 58.2 M | USA |
 |
Cronos Group
CRON
|
212 | $ 2.58 | -2.64 % | $ 1.32 B |  Canada |
 |
Catalent
CTLT
|
41.8 | - | - | $ 11.5 B | USA |
 |
Alimera Sciences
ALIM
|
309 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
111 | - | -23.39 % | $ 1.76 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
775 | $ 4.21 | -1.64 % | $ 59.2 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
224 | - | - | $ 2.06 B |  France |
 |
DURECT Corporation
DRRX
|
519 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
75.6 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
39.3 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
5.36 K | - | - | $ 36.6 M | USA |
 |
Bausch Health Companies
BHC
|
78.1 | $ 5.59 | -1.41 % | $ 2.04 B | Canada |
 |
Harrow Health
HROW
|
199 | $ 40.24 | -0.59 % | $ 1.48 B | USA |
 |
Jupiter Wellness
JUPW
|
318 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
36.8 | - | 1.15 % | $ 7.11 M | USA |
 |
Evolus
EOLS
|
59.4 | $ 5.18 | -1.71 % | $ 334 M | USA |
 |
Emergent BioSolutions
EBS
|
55.8 | $ 7.99 | -2.92 % | $ 409 M | USA |
 |
Organogenesis Holdings
ORGO
|
94 | $ 2.3 | -4.17 % | $ 303 M | USA |
 |
Pacira BioSciences
PCRX
|
37.3 | $ 25.14 | -1.06 % | $ 1.16 B | USA |
 |
Radius Health
RDUS
|
274 | - | - | $ 1.42 B | USA |
 |
ProPhase Labs
PRPH
|
45.4 | - | - | $ 5.07 M | USA |
 |
Assertio Holdings
ASRT
|
122 | $ 18.05 | 0.06 % | $ 116 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
32.3 | $ 1.06 | 1.92 % | $ 1.32 M | USA |
 |
PetIQ
PETQ
|
54.2 | - | 1.64 % | $ 400 M | USA |
 |
Tilray
TLRY
|
53 | $ 6.14 | -6.4 % | $ 3.79 B | Canada |
 |
Recro Pharma
REPH
|
6.63 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
194 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
20.2 | $ 0.93 | -5.22 % | $ 46.4 M | USA |
 |
Veru
VERU
|
264 | $ 2.24 | -2.18 % | $ 302 M | USA |
 |
Viatris
VTRS
|
64 | $ 14.97 | 1.01 % | $ 18 B | USA |
 |
cbdMD
YCBD
|
84 | $ 0.87 | -4.67 % | $ 3.75 M | USA |
 |
Aurora Cannabis
ACB
|
-807 | $ 3.29 | -3.8 % | $ 86.3 M | Canada |
 |
Zomedica Corp.
ZOM
|
64.3 | - | -0.21 % | $ 98 M | USA |
 |
Rockwell Medical
RMTI
|
15.4 | $ 0.9 | 1.11 % | $ 32.4 M | USA |
 |
China Pharma Holdings
CPHI
|
47.6 | $ 0.52 | -7.82 % | $ 2.23 M |  China |
 |
TherapeuticsMD
TXMD
|
723 | $ 2.11 | 0.48 % | $ 24.4 M | USA |